logo

For the Inventor, By the Inventor

Berkeley, CA, United States of America

Dynavax Technologies Corporation


USPTO Granted Patents = 66

% Expired Patents = 36.4



Trademarks = 14

Forward Citations = 998

Loading Chart...
Loading Chart...

55 inventors (with patents filed for the assignee):

goldMedal Robert L Coffman (23 out of 29 patents)

silverMedal Karen L Fearon (21 out of 26 patents)

bronzeMedal Dino Dina (19 out of 38 patents)

4.  Stephen F Tuck (19 out of 19 patents)

5.  Gary Van Nest (13 out of 23 patents)

6.  Cristiana Guiducci (11 out of 12 patents)

7.  Franck J Barrat (8 out of 11 patents)

8.  Radwan Kiwan (7 out of 9 patents)

9.  Jason Marshall (5 out of 6 patents)

10.  Robert S Janssen (5 out of 6 patents)

11.  Stewart D Chipman (4 out of 6 patents)

12.  Gary S Ott (4 out of 23 patents)

13.  David Novack (4 out of 4 patents)

14.  Albert Frederick Candia, Iii (3 out of 3 patents)

15.  Richard Thomas Beresis (3 out of 6 patents)


Core Competencies:
Vaccines
Toll-Like Receptors
Immunogenicity
CpG-Adjuvanted
Immunostimulatory Oligonucleotides
Chimeric Compounds
Inhibitory Oligonucleotides
Biodegradable Formulations
Cancer Treatment
SARS-CoV-2
Autoimmunity
Hepatitis B

66 patents:

1. 12605442 - Production of vaccines comprising inactivated SARS-CoV-2 viral particles (2026-04-21),
2. 12569553 - SHINGLES VACCINES COMPRISING A TLR9 AGONIST (2026-03-10),
3. 12378255 - Toll-like receptor antagonist compounds and methods of use (2025-08-05),
4. 12364745 - Immunogenicity of a CpG-adjuvanted recombinant plague vaccine (2025-07-22),
5. 12296002 - Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2025-05-13),
6. 11981670 - Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof (2024-05-14),
7. 11827641 - Toll-like receptor antagonist compounds and methods of use (2023-11-28),
8. 11684669 - CpG-adjuvanted SARS-CoV-2 virus vaccine (2023-06-27),
9. 11370794 - Toll-like receptor antagonist compounds and methods of use (2022-06-28),
10. 11124510 - Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof (2021-09-21),
11. 10751412 - Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer (2020-08-25),
12. 10722591 - Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof (2020-07-28),
13. 10618896 - Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof (2020-04-14),
14. 10548975 - Branched chimeric compounds, and methods of use thereof (2020-02-04),
15. 10369168 - Administration of polynucleotide toll-like receptor 9 agonists for treating cancer (2019-08-06),
Dynavax Technologies Corporation, based in Berkeley, California, specializes in the development of immunomodulatory compounds, focusing on innovative vaccine technologies. The company is recognized for its expertise in Toll-Like Receptors and immunogenicity, particularly through the use of CpG-adjuvanted formulations and immunostimulatory oligonucleotides. Dynavax is committed to advancing therapeutic solutions that enhance immune responses, leveraging its knowledge in chimeric and inhibitory oligonucleotides, as well as biodegradable formulations.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

66 Patents

#8 in Berkeley, CA

#1,287 in California

#5,522 in US

#11,155 in the World

Berkeley, CA (US)
Berkeley, CA, United States of America

Dynavax Technologies Corporation

Forward Citations = 998

55 inventors:

goldMedal Robert L Coffman (23 out of 29 patents)

silverMedal Karen L Fearon (21 out of 26 patents)

bronzeMedal Dino Dina (19 out of 38 patents)

4.  Stephen F Tuck (19 out of 19 patents)

5.  Gary Van Nest (13 out of 23 patents)

Please report any incorrect information to [email protected]
Loading…